Oncolytic virotherapy armed with an engineered interfering lncRNA exhibits antitumor activity by blocking the epithelial mesenchymal transition in triple-negative breast cancer.
Saved in:
| Title: | Oncolytic virotherapy armed with an engineered interfering lncRNA exhibits antitumor activity by blocking the epithelial mesenchymal transition in triple-negative breast cancer. |
|---|---|
| Authors: | Ang, Lin1 (AUTHOR), Guo, Lingli1,2 (AUTHOR), Wang, Jin1 (AUTHOR), Huang, Jin1 (AUTHOR), Lou, Xiaoli1,3 (AUTHOR) dovecrane@163.com, Zhao, Min1 (AUTHOR) zhao.min.hi@163.com |
| Source: | Cancer Letters. Jun2020, Vol. 479, p42-53. 12p. |
| Database: | Academic Search Ultimate |
| ISSN: | 03043835 |
|---|---|
| DOI: | 10.1016/j.canlet.2020.03.012 |
